HCID 178488043、化合物 → HCID 178524063、化合物
反応式
C[O:2][C:3]1[CH:12]=[CH:11][C:10]2[NH:9][C:8]3=[CH:13][C:14]([C:16]([OH:18])=[O:17])=[N:15][N:7]3[C:6](=[O:19])[C:5]=2[CH:4]=1>Br.C(O)(=O)C.O>[OH:2][C:3]1[CH:12]=[CH:11][C:10]2[NH:9][C:8]3=[CH:13][C:14]([C:16]([OH:18])=[O:17])=[N:15][N:7]3[C:6](=[O:19])[C:5]=2[CH:4]=1参加物
5
実験手順
A suspension of 4,9-dihydro-7-methoxy-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid (2.0 g; 0.0077 mole) in 48% hydrobromic acid (30 ml) and glacial acetic acid (50 ml) is refluxed for 23 hrs. The mixture is cooled and then diluted with water (25 ml). The product, which precipitates out, is collected by filtration and recrystallized from DMF-Ether (1:1, 90 ml). Yield 1.1 g; mp 285°-286° C. (d).
後処理
- temperatureis refluxed for 23 hrs
- temperatureThe mixture is cooled
- customThe product, which precipitates out
- filtrationis collected by filtration
- customrecrystallized from DMF-Ether (1:1, 90 ml)
出典と根拠
- ORDレコード
- ord-18fa4349312740089f5bb05920fe843a
- 出典データセット
- uspto-grants-1981_04
- 特許番号
- US04261996
反応ノート
読み込み中…